Fourth Serbian Congress on Menopause and Involutional Hypoandrogenism
Effects of Exogenous and Endogenous Factors on Endocrinology of Sex
Friday, October 14, 2022 • Hilton Hotel, Belgrade
08.00-17.00 registracija
09.45-10.00
Opening of the Congress - Prof. dr Svetlana Vujović
First session –
Session Chairs: John Stevenson (UK), Mark Brincat (Malta), Svetlana Vujović (Serbia)
10.00-10.15
John Stevenson (UK): Hormone Replacement Therapy in Women with Increased Cardiovascular Risk – Do We Dare to Use It? – da li se usuđujemo da je primenimo?
10.15-10.30
Mark Brincat (Malta): E4 Preparations – A New Estrogen in Menopausal Hormone Therapy
10.30-10.45
Nick Panay (UK): Testosterone Replacement Therapy in Women – Are There Any New Developments?
10.45-11.00
Svetlana Dragojević Dikić (Serbia): Menopause in Focus – A Contemporary Therapeutic Concept
11.00–11.15
Mick van Trotsenburg (Austria): The Nuances of Gender Transition in Midlife and Beyond
11.15–11.30
Svetlana Vujović (Serbia): The Role of Progesterone in Gender-Affirming Hormone Therapy for Transgender Women
Branka Nikolić (Serbia): The Epidemic of Postmenopausal Asymptomatic Endometrial Polyps Versus the Challenges of Advanced Diagnostics
18.00–18.15
Vinka Vukotić (Serbia): Genitourinary Syndrome of Menopause
18.15–18.30
Damir Franić (Slovenia): Radiofrequency Treatment of Overactive Bladder and Urgency Urinary Incontinence – A Pilot Study
18.45–19.00
Svetlana Janković (Serbia): Treatment of Stress Urinary Incontinence in Menopause Using CO₂ Laser Therapy
19.00–19.15
Aleksandar Milošević (Serbia): Testosterone – The Treatment of Choice for Men Over 50 Years of Age
19.15–19.30 Komercijalni simpozijum L’Oréal
20.00
Aleksandar Milošević (Serbia): Testosterone – The Treatment of Choice for Men Over 50 Years of Age
Saturday, October 15, 2022
Fifth session –
Session Chairs: Mick van Trotsenburg (Austria), Mark Brincat (Malta), Ljiljana Marina (Serbia)
08.00–08.10
Antoan Stefan Šojat (Serbia): Adrenal Tumorigenesis, Obesity, and Menopause
08.10–08.20
Tijana Petković (Serbia): The Endometrial Microenvironment as a Predictor of Successful Pregnancy
08.20–08.30
Natalija Antić (Serbia): Can We Rely on Patient Self-Reported Data Regarding Menstrual Cycle Regularity?
08.40–08.50
Anđela Bošković (Serbia): Postpartum Insulin Levels in Women with PCOS Treated with Metformin During Pregnancy
09.00–09.05
Dunja Simona Petković (Serbia): Effects of Autonomous Cortisol Secretion and Possible Autonomous Cortisol Secretion on Body Mass Index in Patients with Adrenal Incidentalomas
09.05–09.10
Kristina Saravinovska (Serbia): The Impact of the COVID-19 Pandemic on Women's Reproductive Health
Jasmina Ćirić (Serbia): The Role of Aldosterone in Metabolic and Cardiovascular Disorders
09.30–09.45
Miomira Ivović (Serbia): Quality of Life in Women with Premature Ovarian Insufficiency
09.45–10.00
Ljiljana Marina (Serbia): Sex Steroids and the Breast
10.00–10.15
Sanja Ognjanović (Serbia): Body Composition and Metabolic Status of Postmenopausal Women with Adrenal Incidentaloma
10.15–10.30
Miloš Stojanović (Serbia): Blood Pressure in Menopausal Women on Different Therapeutic Regimens
10.30–10.45
Marija Miletić (Serbia): Hyperthyroidism and Primary Hyperparathyroidism – A Hidden Connection?
10.45–11.00
Coffee break
11.00–11.15 Commercial Symposium – Amicus
12.15–12.30 Commercial Symposium – Optimuspharm
Seventh Session –
Session Chairs: Nebojša Lalić (Serbia), Katarina Lalić (Serbia), Aleksandra Jotić (Serbia
11.30–11.45
Nebojša Lalić (Serbia): New Drugs in Diabetes Therapy – Their Impact on Insulin Resistance
11.45–12.00
Katarina Lalić (Serbia): Advances in Dyslipidemia Treatment – Towards More Effective Atherosclerosis Prevention
12.00–12.15
Aleksandra Jotić (Serbia): Previous Gestational Diabetes as a Marker of Cardiovascular Risk During the Climacteric Period
12.15–12.30
Snježana Popović Pejičić (Bosnia and Herzegovina): Obesity as a Consequence of the Modern Lifestyle
12.30–12.45
Snežana Polovina (Serbia): Obesity and the Female Reproductive System Throughout Life
12.45–13.00
Lidija Injac Stevanović (Montenegro): Can Insulin Levels Be a Prognostic Factor for the Development of Treatment Resistance in Patients with Schizophrenia?
Aleksandar Krunić (USA): Skin Treatments in Menopause
13.30–13.45
Anna Biljana Chapman (UK): Decline and Irregularities of Sex Hormones in Perimenopause and Their Manifestations on the Skin and Hair from a Dermatological Perspective
13.45–14.00
Vesna Srećković Dimitrijević (Serbia): Acne and Polycystic Ovary Syndrome
14.00–14.15
Marina Nikolić Đurović (Serbia): Contemporary Treatment of Osteoporosis in Menopause
14.15–14.30
Olivera Ilić Stojanović (Serbia): The Impact of Osteoporosis on Callus Formation
Biljana Beleslin (Serbia): Contemporary Principles in the Treatment of Graves’ Orbitopathy
17.45–18.00
Mirjana Stojković (Serbia): Subclinical Hypothyroidism and Aging
18.00–18.15
Zoran Gluvić (Serbia): Non-Alcoholic Fatty Liver Disease – A Multidisciplinary Clinical Approach and Institutional Adaptation to Current Clinical Practice Guidelines
18.15–18.30
Branko Barać (Serbia): Effects of Endogenous Testosterone on COVID-19 Infection
18.30–18.40
Jelena Milić (Serbia): Alcoholism and Prescription Drug Misuse During the Menopausal Transition and Menopause
18.40–18.50
Zorana Arizanović (Serbia): The Impact of Weight Loss on Premenstrual Syndrome Symptoms